Literature DB >> 15770089

Mutation of L4 ribosomal protein conferring unusual macrolide resistance in two independent clinical isolates of Staphylococcus aureus.

Anne-Laure Prunier1, Hiep N'Guyen Trong, Didier Tande, Christine Segond, Roland Leclercq.   

Abstract

The aim of this study was to characterize the resistance mechanisms of two strains of Staphylococcus aureus UCN42 and UCN43 isolated from cystic fibrosis patients that displayed an unusual phenotype of resistance to macrolides. The strains were resistant to erythromycin and the 16-membered macrolide spiramycin but susceptible to clindamycin. None of the strains contained erm or msr(A) genes by PCR. Sequencing of genes encoding ribosomal targets of macrolides revealed mutations in conserved regions of the L4 ribosomal protein, a R168S mutation for S. aureus UCN43 and mutations at positions G69A and T70P for both strains. This observation extends previous reports of similar mutations in streptococci and mycoplasma to S. aureus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770089     DOI: 10.1089/mdr.2005.11.18

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  9 in total

1.  Chemistry and biology of macrolide antiparasitic agents.

Authors:  Younjoo Lee; Jun Yong Choi; Hong Fu; Colin Harvey; Sandeep Ravindran; William R Roush; John C Boothroyd; Chaitan Khosla
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

2.  Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Klaudia Kosowska-Shick; Catherine Clark; Kim Credito; Pamela McGhee; Bonifacio Dewasse; Tatiana Bogdanovich; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Detection of linezolid-resistant Staphylococcus aureus with 23S rRNA and novel L4 riboprotein mutations in a cystic fibrosis patient in Spain.

Authors:  Federico Román; Carolina Roldán; Pilar Trincado; Carmen Ballesteros; Concepción Carazo; Ana Vindel
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

Review 4.  The macrolide antibiotic renaissance.

Authors:  George P Dinos
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

Review 5.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

6.  Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).

Authors:  Jeffrey B Locke; Mark Hilgers; Karen Joy Shaw
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

7.  Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics.

Authors:  Elie J Diner; Christopher S Hayes
Journal:  J Mol Biol       Date:  2009-01-03       Impact factor: 5.469

Review 8.  Molecular Mechanisms of Drug Resistance in Staphylococcus aureus.

Authors:  Beata Mlynarczyk-Bonikowska; Cezary Kowalewski; Aneta Krolak-Ulinska; Wojciech Marusza
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

9.  Twenty-seven-nucleotide repeat insertion in the rplV gene confers specific resistance to macrolide antibiotics in Staphylococcus aureus.

Authors:  Dianpeng Han; Yu Liu; Jingjing Li; Chenghua Liu; Yaping Gao; Jiannan Feng; Huizhe Lu; Guang Yang
Journal:  Oncotarget       Date:  2018-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.